Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1983 2
1984 4
1987 1
1988 2
1989 11
1990 8
1991 13
1992 3
1993 5
1994 7
1995 6
1996 10
1997 5
1998 4
1999 7
2000 6
2001 11
2002 7
2003 10
2004 7
2005 6
2006 5
2007 9
2008 4
2009 10
2010 9
2011 9
2012 16
2013 16
2014 17
2015 13
2016 19
2017 15
2018 18
2019 16
2020 20
2021 17
2022 20
2023 15
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

360 results

Results by year

Filters applied: . Clear all
Page 1
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Cremolini C, Antoniotti C, Rossini D, Lonardi S, Loupakis F, Pietrantonio F, Bordonaro R, Latiano TP, Tamburini E, Santini D, Passardi A, Marmorino F, Grande R, Aprile G, Zaniboni A, Murgioni S, Granetto C, Buonadonna A, Moretto R, Corallo S, Cordio S, Antonuzzo L, Tomasello G, Masi G, Ronzoni M, Di Donato S, Carlomagno C, Clavarezza M, Ritorto G, Mambrini A, Roselli M, Cupini S, Mammoliti S, Fenocchio E, Corgna E, Zagonel V, Fontanini G, Ugolini C, Boni L, Falcone A; GONO Foundation Investigators. Cremolini C, et al. Among authors: roselli m. Lancet Oncol. 2020 Apr;21(4):497-507. doi: 10.1016/S1470-2045(19)30862-9. Epub 2020 Mar 9. Lancet Oncol. 2020. PMID: 32164906 Free article. Clinical Trial.
Gender Differences in Cancer-associated Venous Thromboembolism.
Riondino S, Guadagni F, Formica V, Ferroni P, Roselli M. Riondino S, et al. Among authors: roselli m. Curr Med Chem. 2017;24(24):2589-2601. doi: 10.2174/0929867323666161018144505. Curr Med Chem. 2017. PMID: 27758714 Review.
Use of Synbiotics for Ulcerative Colitis Treatment.
Roselli M, Finamore A. Roselli M, et al. Curr Clin Pharmacol. 2020;15(3):174-182. doi: 10.2174/1574884715666191226120322. Curr Clin Pharmacol. 2020. PMID: 31878863 Review.
HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling.
Formica V, Riondino S, Morelli C, Guerriero S, D'Amore F, Di Grazia A, Del Vecchio Blanco G, Sica G, Arkenau HT, Monteleone G, Roselli M. Formica V, et al. Among authors: roselli m. Br J Cancer. 2023 Aug;129(2):222-236. doi: 10.1038/s41416-023-02266-2. Epub 2023 Apr 20. Br J Cancer. 2023. PMID: 37081189 Review.
Sex-Genetic Interaction in the Risk for Cerebrovascular Disease.
Pastore D, Pacifici F, Capuani B, Palmirotta R, Dong C, Coppola A, Abete P, Roselli M, Sbraccia P, Guadagni F, Lauro D, Rundek T, Della-Morte D. Pastore D, et al. Among authors: roselli m. Curr Med Chem. 2017;24(24):2687-2699. doi: 10.2174/0929867324666170417100318. Curr Med Chem. 2017. PMID: 28413964 Review.
Obesity-driven inflammation and colorectal cancer.
Vazzana N, Riondino S, Toto V, Guadagni F, Roselli M, Davi G, Ferroni P. Vazzana N, et al. Among authors: roselli m. Curr Med Chem. 2012;19(34):5837-53. doi: 10.2174/092986712804143349. Curr Med Chem. 2012. PMID: 23033947 Review.
Monoclonal antibodies in gastrointestinal cancers.
Bronte G, Cicero G, Cusenza S, Galvano A, Musso E, Rizzo S, Sortino G, Roselli M, Bazan V, Fiorentino E, Russo A. Bronte G, et al. Among authors: roselli m. Expert Opin Biol Ther. 2013 Jun;13(6):889-900. doi: 10.1517/14712598.2013.774367. Epub 2013 Feb 27. Expert Opin Biol Ther. 2013. PMID: 23441760 Free article. Review.
360 results